What is the price of QuantRx Biomedical Corporation (QTXB)

The price of QuantRx Biomedical Corporation (QTXB) is $0.0005

What is the market cap of QuantRx Biomedical Corporation (QTXB)

The market cap of QuantRx Biomedical Corporation (QTXB) is $118.05K

QuantRx Biomedical Corporation (QTXB) Revenue

QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.

Year	Revenue	Change
Not enough data for the provided dates.

Year

Revenue

Change

Not enough data for the provided dates.

Company	Revenue	Revenue Difference	Country
Intuitive Surgical, Inc. ISRG.US	$11.03B	-	US
EssilorLuxottica S.A. EL.PA	$34.74B	-	FR
HOYA Corporation 7741.T	-	-	JP
Becton, Dickinson and Company BDX.US	$20.84B	-	US
Alcon Inc. ALC.SW	-	-	CH

Company

Revenue

Revenue Difference

Country